二重エネルギーX線吸収測定の2030年までの市場予測：タイプ、技術、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界の二重エネルギーX線吸収測定（DEXA）市場は、2023年に6億1,952万米ドルを占め、予測期間中にCAGR 10.0％で成長し、2030年には12億727万米ドルに達すると予測されています。

骨密度（BMD）と体組成は、二重エネルギーX線吸収測定法（DEXA）を用いることで、侵襲性を伴わずに正確に測定することができます。DEXAは、2つの異なるエネルギーレベルの低線量X線ビームを使用して骨、脂肪、除脂肪組織を区別することにより、個人の骨格の健康状態や体全体の組成に関する正確な情報を提供します。DEXA検査は骨粗鬆症の評価によく用いられ、骨折リスクや骨塩量減少の判定に有用です。

国際骨粗鬆症財団によると、50歳以上の女性の約3人に1人、男性の約5人に1人が骨粗鬆症に罹患しているといいます。同団体はまた、米国、欧州、日本で7,500万人以上の患者が骨粗鬆症に関連していると推定しています。

増加する高齢者人口

加齢に伴う骨量減少、つまり骨粗鬆症は、世界の高齢者人口の増加に伴い、より一般的になってきています。DEXAは、骨折やそれに伴う合併症を避けるための迅速な介入を可能にする重要な診断ツールであるため、この脆弱性の診断に不可欠です。さらに、定期的なDEXA検査は、高齢化人口の継続的な健康管理に必要であり、高齢者ヘルスケアへの早期アプローチを促します。

機器とメンテナンス費用

ヘルスケア施設は、DEXA装置の初期資本支出だけでなく、継続的なメンテナンス費用で財政難に直面する可能性があります。これらの費用は、複雑な技術と精度を保証するために必要な絶え間ない校正によって左右されます。さらに、この経済的要因は、ヘルスケア計画における財政的考慮の必要性を強調し、特に資源が乏しい環境では、DEXAが広く採用されるのを妨げるかもしれないです。

研究と医薬品開発への応用の増加

臨床診断にとどまらず、DEXAは研究用途にも使用でき、薬が骨の健康にどのように影響するかを評価するのに有用なツールです。さらに、骨の組成と密度の変化を追跡するDEXAの機能は、骨粗鬆症のような疾患に対してより効果的で集中的な治療を可能にし、薬剤開発に不可欠な情報を提供します。この分野でのさらなる調査の機会は、製薬会社と学術機関との提携によってもたらされます。

代替技術と競合環境

新たな代替技術や競合情勢の変化は、DEXA市場にとって脅威となります。市場におけるDEXAの優位性は、定量的コンピュータ断層撮影法（QCT）や末梢定量的コンピュータ断層撮影法（pQCT）のような競合診断モダリティによって脅かされています。さらに、代替技術の市場開拓が進み、従来のDEXAシステムから資本や注目が離れれば、市場シェアや普及率にも影響が及ぶ可能性があります。

COVID-19の影響：

二重エネルギーX線吸収測定法（DEXA）市場は、COVID-19の流行によって大きな影響を受けています。ヘルスケアサービスの中断、パンデミック関連の課題に対処するためのリソースの再配分、安全性への懸念の高まりの結果、DEXAスキャンなどの定期的な診断処置は減少しました。さらに、DEXA技術の導入は、ヘルスケア施設への患者の受診の減少、緊急でない診療予約の遅れ、ヘルスケア予算の財政的制約など、さまざまな要因が重なり、一時的に停滞しています。しかし、パンデミックは予防医療の価値をも浮き彫りにしており、医療システムがパンデミック後の回復期に定期的なスクリーニングと診断処置を最優先する限り、DEXAが復活する見込みがあります。

予測期間中、軸方向DEXA骨密度計セグメントが最大になる見込み

軸DEXA骨密度計は、二重エネルギーX線吸収測定法（DEXA）において最大の市場シェアを占めると予測されています。これらの機器は主に、骨折や骨粗鬆症のリスクを評価する上で重要な部位である股関節と脊椎の骨密度を評価するために使用されます。軸DEXAスキャンは、骨の健康状態に関する極めて正確で包括的な情報を提供することで、医師が骨粗鬆症のような疾患を診断し、治療の有効性を評価するのに役立っています。さらに、骨格の中心部位の徹底的な検査が可能なため、さまざまなヘルスケア環境の臨床医がアキシャル構成を好んでいます。骨粗鬆症がより一般的になり、骨の健康がより重要になるにつれ、軸型DEXA骨密度計は常に病気の管理と予防医療の提供に不可欠なものとなるであろう。

体組成分析セグメントは予測期間中最も高いCAGRが見込まれる

体組成分析分野では、二重エネルギーX線吸収測定法（DEXA）市場が最も高いCAGRで成長すると予測されます。高度診断ツールの市場は、体組成が全体的な健康、フィットネス、疾病予防に及ぼす影響に対する意識の高まりによって牽引されています。従来の骨密度検査にとどまらず、体組成分析では除脂肪体重、脂肪分布、その他の重要な要素を徹底的に分析することができます。さらに、肥満、代謝障害、筋肉の衰えを引き起こす疾患を取り巻く世界の懸念に対処するためには、技術が不可欠です。

最大のシェアを持つ地域：

最大のシェアを持つ北米は、二重エネルギーX線吸収測定（DEXA）市場において支配的な地位を保ち続けています。特に米国では、ヘルスケア産業が確立され、技術的に洗練されており、医療研究への多額の支出、最先端の機器、広大なインフラがあります。さらに、この地域の優位性は、高水準のヘルスケア支出、強力な規制環境、技術革新の継続的重視によって強調されています。このため、米国を中心とする北米は、世界のヘルスケアセクターの発展に大きな影響を与え続けています。

CAGRが最も高い地域：

アジア太平洋地域のCAGRが予測期間中最も高くなると予想されます。ヘルスケア・インフラへの投資の増加、医療ニーズの進化に伴う高齢化、医療意識の高まりなどが、この顕著な成長の要因となっています。医薬品、医療技術、ヘルスケアサービスの先進国は、中国、インド、日本です。さらに、この地域がデジタルヘルスソリューションに重点を置いていること、政府の取り組みが奨励されていることなどが、アジア太平洋地域を変化するヘルスケアの主要拠点として位置づけており、市場の複合年間成長率上昇に大きく寄与しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 技術分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の二重エネルギーX線吸収測定（DEXA）市場：タイプ別

• スタンドアロン
• ポータブル
• その他のタイプ

第6章 世界の二重エネルギーX線吸収測定（DEXA）市場：技術別

• 軸方向DEXA骨密度計
• 末梢DEXA骨密度計
• その他の技術

第7章 世界の二重エネルギーX線吸収測定（DEXA）市場：用途別

• 骨粗鬆症
• 体組成分析
• 骨折の管理
• 骨密度測定
• その他の用途

第8章 世界の二重エネルギーX線吸収測定（DEXA）市場：エンドユーザー別

• 病院とクリニック
• 診断センター
• 専門センター
• その他のエンドユーザー

第9章 世界の二重エネルギーX線吸収測定（DEXA）市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東・アフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Osteometer Meditech Inc
• Medilink International
• GE Healthcare
• Shenzhen XRAY Electric Co., Ltd.
• BeamMed Ltd
• Furuno Electric Co., Ltd.
• Hologic, Inc.
• Scanflex Healthcare AB
• Medonica Co., Ltd
• Fonar Corporation
• Swissray Medical AG

List of Tables

• Table 1 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 4 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 5 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 6 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 7 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 8 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 9 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 10 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 11 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 12 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 13 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 14 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 15 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 17 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 18 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 19 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 20 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 21 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 23 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 24 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 25 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 26 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 27 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 28 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 29 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 30 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 31 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 32 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 33 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 34 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 35 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 36 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 37 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 38 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 39 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 40 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 41 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 43 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 44 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 45 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 46 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 47 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 48 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 49 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 50 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 51 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 52 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 53 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 54 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 55 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 56 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 57 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 58 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 59 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 60 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 63 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 64 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 65 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 66 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 67 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 68 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 69 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 70 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 71 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 72 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 73 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 74 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 75 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 76 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 77 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 78 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 79 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 80 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 81 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 83 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 84 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 85 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 86 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 87 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 88 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 89 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 90 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 91 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 92 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 93 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 94 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 95 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 96 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 97 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 98 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 99 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 100 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 101 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2021-2030) ($MN)
• Table 103 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2021-2030) ($MN)
• Table 104 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2021-2030) ($MN)
• Table 105 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2021-2030) ($MN)
• Table 106 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2021-2030) ($MN)
• Table 107 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2021-2030) ($MN)
• Table 108 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2021-2030) ($MN)
• Table 109 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 110 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2021-2030) ($MN)
• Table 111 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2021-2030) ($MN)
• Table 112 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2021-2030) ($MN)
• Table 113 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2021-2030) ($MN)
• Table 114 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2021-2030) ($MN)
• Table 115 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 116 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2021-2030) ($MN)
• Table 117 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 118 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 119 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 120 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Dual-energy X-ray Absorptiometry (DEXA) Market is accounted for $619.52 million in 2023 and is expected to reach $1207.27 million by 2030 growing at a CAGR of 10.0% during the forecast period. Bone mineral density (BMD) and body composition can be measured with accuracy and without invasiveness using dual-energy X-ray absorptiometry (DEXA). DEXA provides precise information about an individual's skeletal health and overall body composition by using low-dose X-ray beams at two different energy levels to differentiate between bone, fat, and lean tissue. DEXA scans are frequently used to evaluate osteoporosis and are useful in determining fracture risk and bone mineral loss.

According to the International Osteoporosis Foundation, around one in three women and one in five men over the age of 50 are suffering from osteoporosis. The organization also estimated that over 75 million patients are associated with osteoporosis in the U.S., Europe, and Japan.

Market Dynamics:

Driver:

Increasingly elderly population

Age-related bone loss, or osteoporosis, is becoming more common as the world's senior population grows. DEXA is essential for diagnosing this vulnerability because it is a critical diagnostic tool that enables prompt interventions to avoid fractures and associated complications. Additionally, regular DEXA scans are required for the ongoing health management of the aging population, which encourages an early approach to senior healthcare.

Restraint:

Equipment and maintenance costs

Healthcare facilities may face financial difficulties with the initial capital expenditure for DEXA equipment as well as continuing maintenance costs. The cost of all this is influenced by the complex technology and constant calibration needed to ensure accuracy. Furthermore, this financial factor highlights the need for financial considerations in healthcare planning and may prevent DEXA from being widely adopted, particularly in settings where resources are scarce.

Opportunity:

Increasing research and drug development applications

Beyond clinical diagnostics, DEXA can be used in research applications and is a useful tool for evaluating how medications affect bone health. Moreover, its function in tracking alterations in the composition and density of bone offers vital information for medication development, enabling more effective and focused treatments for diseases like osteoporosis. Opportunities for more research in this area are provided by partnerships between pharmaceutical companies and academic institutions.

Threat:

Alternative technologies and the competitive environment

Emerging alternative technologies and changing competitive landscapes pose threats to the DEXA market. The dominance of DEXA in the market is threatened by competing diagnostic modalities like quantitative computed tomography (QCT) and peripheral quantitative computed tomography (pQCT). Additionally, market share and adoption rates may be impacted if ongoing developments in alternative technologies draw capital and attention away from conventional DEXA systems.

COVID-19 Impact:

The market for dual-energy X-ray absorptiometry (DEXA) has been greatly impacted by the COVID-19 pandemic. Routine diagnostic procedures, such as DEXA scans, have decreased as a result of disruptions to healthcare services, the reallocation of resources to address pandemic-related challenges, and increased safety concerns. Furthermore, the adoption of DEXA technology has temporarily stalled due to a combination of factors, including fewer patient visits to healthcare facilities, delays in non-urgent medical appointments, and financial constraints on healthcare budgets. But the pandemic has also highlighted the value of preventive healthcare, which may present prospects for DEXA's comeback as long as healthcare systems give regular screenings and diagnostic procedures top priority during the post-pandemic recovery period.

The Axial DEXA Bone Densitometer segment is expected to be the largest during the forecast period

It is projected that axial DEXA bone densitometers will command the largest market share in dual-energy X-ray absorptiometry (DEXA). These instruments are mainly used to assess the bone mineral density in the hip and spine, which are important regions to assess the risk of fractures and osteoporosis. Axial DEXA scans help physicians diagnose diseases like osteoporosis and evaluate the efficacy of treatments by giving them extremely precise and comprehensive information about bone health. Moreover, clinicians in a variety of healthcare settings prefer the axial configuration because it enables a thorough examination of central skeletal sites. As osteoporosis becomes more common and bone health becomes more important, axial DEXA bone densitometers will always be essential for managing diseases and providing preventive care.

The Body Composition Analysis segment is expected to have the highest CAGR during the forecast period

The market for dual-energy X-ray absorptiometry (DEXA) is expected to grow at the highest CAGR in the body composition analysis segment. The market for advanced diagnostic tools has been driven by growing awareness of the influence of body composition on overall health, fitness, and disease prevention. Beyond conventional bone density tests, body composition analysis offers a thorough analysis of lean muscle mass, fat distribution, and other important factors. Additionally, in order to address the global concerns surrounding obesity, metabolic disorders, and conditions that cause muscle wasting, technology is essential.

Region with largest share:

With the largest share, North America has continued to hold a dominant position in the dual-energy X-ray absorptiometry (DEXA) market. Particularly in the United States, the healthcare industry is well-established and technologically sophisticated, with large expenditures made in medical research, state-of-the-art equipment, and a vast infrastructure. Furthermore, the prominence of the region is emphasized by the high level of healthcare spending, the strong regulatory environment, and the ongoing emphasis on innovation. Because of this, North America-led by the United States-continues to have a significant influence on how the global healthcare sector develops.

Region with highest CAGR:

The Asia-Pacific region is expected to have the highest CAGR over the projected period. Growing investments in healthcare infrastructure, an aging population with evolving healthcare needs, and growing healthcare awareness are all factors contributing to this notable growth. Leading nations in the advancement of pharmaceuticals, medical technology, and healthcare services are China, India, and Japan. Additionally, the region's emphasis on digital health solutions, along with encouraging government initiatives, positions Asia-Pacific as a major hub for the changing healthcare landscape and contributes significantly to the market's rising compound annual growth rate.

Key players in the market:

Some of the key players in Dual-energy X-ray Absorptiometry (DEXA) market include Osteometer Meditech Inc, Medilink International, GE Healthcare, Shenzhen XRAY Electric Co., Ltd., BeamMed Ltd, Furuno Electric Co., Ltd., Hologic, Inc., Scanflex Healthcare AB, Medonica Co., Ltd, Fonar Corporation and Swissray Medical AG.

Key Developments:

In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US. The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices. It connects with cardiac rhythm strips and 12-lead ECGs, allowing clinicians to monitor numerous patients at the same time and can receive STEMI notifications.

In October 2023, MediLink Therapeutics, announced today that it has entered into a strategic research collaboration and worldwide license agreement with BioNTech SE, a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, on the development of a next-generation antibody-drug conjugate candidate ("ADC"), against Human Epidermal Growth Factor Receptor 3 (HER3).

In September 2023, Hologic Inc. and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions. CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.

Types Covered:

• Standalone
• Portable
• Other Types

Technologies Covered:

• Axial DEXA Bone Densitometer
• Peripheral DEXA Bone Densitometer
• Other Technologies

Applications Covered:

• Osteoporosis
• Body Composition Analysis
• Fracture Management
• Bone Densitometry
• Other Applications

End Users Covered:

• Hospitals & Clinics
• Diagnostic Centers
• Specialty Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Type

• 5.1 Introduction
• 5.2 Standalone
• 5.3 Portable
• 5.4 Other Types

6 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Technology

• 6.1 Introduction
• 6.2 Axial DEXA Bone Densitometer
• 6.3 Peripheral DEXA Bone Densitometer
• 6.4 Other Technologies

7 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Application

• 7.1 Introduction
• 7.2 Osteoporosis
• 7.3 Body Composition Analysis
• 7.4 Fracture Management
• 7.5 Bone Densitometry
• 7.6 Other Applications

8 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By End User

• 8.1 Introduction
• 8.2 Hospitals & Clinics
• 8.3 Diagnostic Centers
• 8.4 Specialty Centers
• 8.5 Other End Users

9 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Osteometer Meditech Inc
• 11.2 Medilink International
• 11.3 GE Healthcare
• 11.4 Shenzhen XRAY Electric Co., Ltd.
• 11.5 BeamMed Ltd
• 11.6 Furuno Electric Co., Ltd.
• 11.7 Hologic, Inc.
• 11.8 Scanflex Healthcare AB
• 11.9 Medonica Co., Ltd
• 11.10 Fonar Corporation
• 11.11 Swissray Medical AG